Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MYO — Myomo, Inc.

CIK 1423053 MIAMI, FL
Back to MYO Full portfolio

Position in MYO

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$106,618
+$106,618 QoQ
Shares Held
102,518
Ownership
0.259%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 79 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYO Over Time

Shares Held

Position Value (USD)

Derivatives in MYO

reported options exposure · as of Mar 31, 2026
CallValue
$30,555
CallShares
45,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,553,993,098 across 97 Medical Devices names. MYO ranks #76 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 8,597,227 $780,112,377
2 MDT
Medtronic plc
 5,373,877 $420,398,397
3 EW
Edwards Lifesciences Corp
 3,997,925 $361,652,295
4 ZBH
Zimmer Biomet Holdings, Inc.
 3,477,472 $299,375,563
5 BSX
Boston Scientific Corp
 4,987,748 $212,877,084
6 GKOS
GLAUKOS Corp
 1,390,017 $194,268,775
7 GEHC
GE HealthCare Technologies Inc.
 2,367,032 $151,513,717
8 PEN
Penumbra Inc
 448,763 $141,696,917

All Filings in MYO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $106,618 102,518
2026-03-31 $30,555 45,200
2025-12-31 $32,396 35,600
2025-09-30 $15,164 17,000
2025-06-30 $701,113 324,590
2025-06-30 $60,264 27,900
2025-03-31 $1,269,551 263,940
2025-03-31 $253,968 52,800
2024-12-31 $32,200 5,000
2024-12-31 $730,237 113,391
2024-12-31 $74,060 11,500
2024-09-30 $151,177 37,700
2024-09-30 $4,010 1,000
2024-06-30 $1,284 400
2024-06-30 $39,483 12,300
2023-12-31 $335,143 66,895
2023-06-30 $59,839 115,522
2023-03-31 $37,671 50,229
2021-03-31 $170,700 13,336